Evidence map›Paper›PMID 38098567›Full record

ArticleAnnals of medicine and surgery (2012)2023

A massive primary congenital mesoblastic nephroma was successfully managed through open total nephrectomy: a case report.

Raghad Samha, Marah Mansour, Yara AlAwad, Bsher Almaalouli, Reema Mayhoob, Aliaa Al Sabbagh, Rama Aljundi, Ali Barakat

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Raghad SamhaFaculty of Medicine, AlBaath University, Homs.
Marah MansourFaculty of Medicine, Tartous University.
Yara AlAwadFaculty of Medicine, Damascus University, Damascus.
Bsher AlmaalouliFaculty of Medicine, Damascus University, Damascus.
Reema MayhoobFaculty of Medicine, Tishreen University, Latakia, Syrian Arab Republic.
Aliaa Al SabbaghFaculty of Medicine, Damascus University, Damascus.
Rama AljundiFaculty of Medicine, Damascus University, Damascus.
Ali BarakatFaculty of Medicine, Tartous University.
Damascus University · SYAl-Baath University · SYMashreq University · SDMayo Clinic · USTishreen University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Congenital mesoblastic nephroma is the most common renal tumor in children under the age of 6 months, comprising 3-10% of all kidney tumors in children. It is a rare and mostly benign tumor. It divides into cellular, classic, and mixed subtypes. It is typically detected in the third trimester of pregnancy using ultrasonography and magnetic resonance imaging. The best treatment is surgically by completely removing the tumor. Case presentation: We reported a case of a one-day-old female who was born at 31 weeks gestation weighing 1670 g. Preterm labor was due to polyhydramnios, which was diagnosed predelivery. A large mass was detected in the left hypochondrium using computerized tomography, total nephrectomy was performed, and the histopathological examination of the specimen confirmed the diagnosis of congenital mesoblastic nephroma. Clinical discussion and conclusion: Early polyhydramnios could be the most significant sign of renal tumors in infants, especially congenital mesoblastic nephroma.

Indexed as

case reportCMNcongenital mesoblastic nephromakidney tumorsurgeryultrasound

Identifiers

PMID38098567
PMCPMC10718342
OpenAlexW4387524263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.